308 related articles for article (PubMed ID: 9148007)
1. Hepatic stellate cells (Ito cells) but not collagen IV may partly be responsible for lower portal pressure after reversing secondary biliary cirrhosis in the rat.
Zimmermann H; Fellay M; Zimmermann A
J Hepatol; 1997 Jan; 26(1):158-66. PubMed ID: 9148007
[TBL] [Abstract][Full Text] [Related]
2. Decreased constitutive hepatic nitric oxide synthase expression in secondary biliary fibrosis and its changes after Roux-en-Y choledocho-jejunostomy in the rat.
Zimmermann H; Kurzen P; Klossner W; Renner EL; Marti U
J Hepatol; 1996 Oct; 25(4):567-73. PubMed ID: 8912158
[TBL] [Abstract][Full Text] [Related]
3. Bilioenteric anastomosis reverses hyperkinetic circulation in bile duct-ligated cirrhotic rats.
Jalink D; Urbanski SJ; Lee SS
J Hepatol; 1996 Dec; 25(6):924-31. PubMed ID: 9007722
[TBL] [Abstract][Full Text] [Related]
4. Effect of losartan, an angiotensin II antagonist, on secondary biliary cirrhosis.
Ramalho LN; Ramalho FS; Zucoloto S; Castro-e-Silva Júnior O; Corrêa FM; Elias Júnior J; Magalhães JF
Hepatogastroenterology; 2002; 49(48):1499-502. PubMed ID: 12397717
[TBL] [Abstract][Full Text] [Related]
5. Soluble guanylyl cyclase stimulation and phosphodiesterase-5 inhibition improve portal hypertension and reduce liver fibrosis in bile duct-ligated rats.
Brusilovskaya K; Königshofer P; Lampach D; Szodl A; Supper P; Bauer D; Beer A; Stift J; Timelthaler G; Oberhuber G; Podesser BK; Seif M; Zinober K; Rohr-Udilova N; Trauner M; Reiberger T; Schwabl P
United European Gastroenterol J; 2020 Dec; 8(10):1174-1185. PubMed ID: 32878579
[TBL] [Abstract][Full Text] [Related]
6. Antagonism of sphingosine 1-phosphate receptor 2 causes a selective reduction of portal vein pressure in bile duct-ligated rodents.
Kageyama Y; Ikeda H; Watanabe N; Nagamine M; Kusumoto Y; Yashiro M; Satoh Y; Shimosawa T; Shinozaki K; Tomiya T; Inoue Y; Nishikawa T; Ohtomo N; Tanoue Y; Yokota H; Koyama T; Ishimaru K; Okamoto Y; Takuwa Y; Koike K; Yatomi Y
Hepatology; 2012 Oct; 56(4):1427-38. PubMed ID: 22505286
[TBL] [Abstract][Full Text] [Related]
7. Proliferation and phenotypic modulation of portal fibroblasts in the early stages of cholestatic fibrosis in the rat.
Tuchweber B; Desmoulière A; Bochaton-Piallat ML; Rubbia-Brandt L; Gabbiani G
Lab Invest; 1996 Jan; 74(1):265-78. PubMed ID: 8569191
[TBL] [Abstract][Full Text] [Related]
8. Intrahepatic upregulation of RhoA and Rho-kinase signalling contributes to increased hepatic vascular resistance in rats with secondary biliary cirrhosis.
Zhou Q; Hennenberg M; Trebicka J; Jochem K; Leifeld L; Biecker E; Sauerbruch T; Heller J
Gut; 2006 Sep; 55(9):1296-305. PubMed ID: 16492715
[TBL] [Abstract][Full Text] [Related]
9. Oxidative-stress-related changes in the livers of bile-duct-ligated rats.
Huang YT; Hsu YC; Chen CJ; Liu CT; Wei YH
J Biomed Sci; 2003; 10(2):170-8. PubMed ID: 12595753
[TBL] [Abstract][Full Text] [Related]
10. Rapid normalization of hepatic glycogen metabolism in rats with long-term bile duct ligation after biliodigestive anastomosis.
Krähenbühl L; Hagenbuch B; Berardi S; Schäfer M; Krähenbühl S
J Hepatol; 1999 Oct; 31(4):656-63. PubMed ID: 10551389
[TBL] [Abstract][Full Text] [Related]
11. Impaired ketogenesis is a major mechanism for disturbed hepatic fatty acid metabolism in rats with long-term cholestasis and after relief of biliary obstruction.
Lang C; Berardi S; Schäfer M; Serra D; Hegardt FG; Krähenbühl L; Krähenbühl S
J Hepatol; 2002 Nov; 37(5):564-71. PubMed ID: 12399220
[TBL] [Abstract][Full Text] [Related]
12. Renal vasoactive mediator generation in portal hypertensive and bile duct ligated rats.
Ackerman Z; Karmeli F; Amir G; Rachmilewitz D
J Hepatol; 1996 Apr; 24(4):478-86. PubMed ID: 8738735
[TBL] [Abstract][Full Text] [Related]
13. Obliteration of portal venules contributes to portal hypertension in biliary cirrhosis.
Shan S; Zhao X; Wood-Trageser MA; Hu D; Liu L; Qi B; Jian J; Wang P; Lv W; Hu C
J Pathol; 2024 Jun; 263(2):178-189. PubMed ID: 38551075
[TBL] [Abstract][Full Text] [Related]
14. Reversibility of hepatic mitochondrial damage in rats with long-term cholestasis.
Krähenbühl L; Schäfer M; Krähenbühl S
J Hepatol; 1998 Jun; 28(6):1000-7. PubMed ID: 9672176
[TBL] [Abstract][Full Text] [Related]
15. Effects of simvastatin, pentoxifylline and spironolactone on hepatic fibrosis and portal hypertension in rats with bile duct ligation.
Oberti F; Pilette C; Rifflet H; Maïga MY; Moreau A; Gallois Y; Girault A; le Bouil A; Le Jeune JJ; Saumet JL; Feldmann G; Calès P
J Hepatol; 1997 Jun; 26(6):1363-71. PubMed ID: 9210625
[TBL] [Abstract][Full Text] [Related]
16. Effect of development on the functional and histological changes induced by bile-duct ligation in the rat.
Zimmermann H; Blaser H; Zimmermann A; Reichen J
J Hepatol; 1994 Feb; 20(2):231-9. PubMed ID: 8006404
[TBL] [Abstract][Full Text] [Related]
17. Increased sinusoidal resistance is responsible for the basal state and endothelin-induced venoconstriction in perfused cirrhotic rat liver.
Shibamoto T; Kamikado C; Koyama S
Pflugers Arch; 2008 Jun; 456(3):467-77. PubMed ID: 18193271
[TBL] [Abstract][Full Text] [Related]
18. Reversibility of secondary biliary fibrosis by biliodigestive anastomosis in the rat.
Zimmermann H; Reichen J; Zimmermann A; Sägesser H; Thenisch B; Höflin F
Gastroenterology; 1992 Aug; 103(2):579-89. PubMed ID: 1634077
[TBL] [Abstract][Full Text] [Related]
19. Terutroban, a TP-receptor antagonist, reduces portal pressure in cirrhotic rats.
Rosado E; Rodríguez-Vilarrupla A; Gracia-Sancho J; Tripathi D; García-Calderó H; Bosch J; García-Pagán JC
Hepatology; 2013 Oct; 58(4):1424-35. PubMed ID: 23703868
[TBL] [Abstract][Full Text] [Related]
20. The liver carnitine pool reflects alterations in hepatic fatty acid metabolism in rats with bile duct ligation before and after biliodigestive anastomosis.
Wächter S; Krähenbühl L; Schäfer M; Krähenbühl S
J Hepatol; 1999 Feb; 30(2):242-8. PubMed ID: 10068103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
